We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

255 hedge funds and large institutions have $3.53B invested in Select Medical in 2021 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 77 increasing their positions, 82 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

370% more call options, than puts

Call options by funds: $19M | Put options by funds: $4.04M

282% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 17

24% more capital invested

Capital invested by funds: $2.86B → $3.53B (+$677M)

23% more funds holding

Funds holding: 208255 (+47)

1.09% more ownership

Funds ownership: 141.63%142.72% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

6% less repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 82

Holders
255
Holders Change
+47
Holders Change %
+22.6%
% of All Funds
4.48%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
65
Increased
77
Reduced
82
Closed
17
Calls
$19M
Puts
$4.04M
Net Calls
+$14.9M
Net Calls Change
+$16.7M
Name Holding Trade Value Shares
Change
Change in
Stake
ECM
151
Everence Capital Management
Indiana
$574K -$236K -14,403 -32%
AB
152
Amalgamated Bank
New York
$559K -$46.4K -2,830 -9%
QC
153
Quadrature Capital
United Kingdom
$530K +$472K +28,805 New
Public Employees Retirement Association of Colorado
154
Public Employees Retirement Association of Colorado
Colorado
$522K
EGM
155
Engineers Gate Manager
New York
$510K +$455K +27,749 New
BC
156
Burney Company
Virginia
$504K -$30.7K -1,875 -6%
Verition Fund Management
157
Verition Fund Management
Connecticut
$500K +$446K +27,226 New
MOACM
158
Mutual of America Capital Management
New York
$491K +$28.6K +1,747 +7%
Qube Research & Technologies (QRT)
159
Qube Research & Technologies (QRT)
United Kingdom
$487K +$434K +26,481 New
Capital Fund Management (CFM)
160
Capital Fund Management (CFM)
France
$482K +$109K +6,654 +34%
QT
161
Quantbot Technologies
New York
$475K +$424K +25,858 New
Natixis Advisors
162
Natixis Advisors
Massachusetts
$460K +$411K +25,067 New
BAM
163
Blueshift Asset Management
New Jersey
$457K -$120K -7,325 -23%
WG
164
Winton Group
United Kingdom
$457K +$408K +24,876 New
IA
165
IndexIQ Advisors
New York
$434K -$37.3K -2,275 -9%
PA
166
Profund Advisors
Maryland
$432K +$32.7K +1,997 +9%
ACM
167
AlphaCrest Capital Management
New York
$432K +$386K +23,517 New
VF
168
Virtu Financial
New York
$425K +$379K +23,113 New
CCA
169
Catalyst Capital Advisors
New York
$416K
AI
170
Atom Investors
Texas
$414K +$90.4K +5,516 +32%
FIM
171
Freedom Investment Management
Connecticut
$409K -$32.2K -1,962 -8%
Teacher Retirement System of Texas
172
Teacher Retirement System of Texas
Texas
$409K +$65.1K +3,972 +22%
CGH
173
Crossmark Global Holdings
Texas
$404K
BCM
174
Bayesian Capital Management
New York
$377K +$337K +20,546 New
LPL Financial
175
LPL Financial
California
$374K -$2.28K -139 -0.7%

SEM Hedge Fund Activity: Q1 2021 in Review

255 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q1 2021, worth a combined $3.53B — up 24% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new SEM positions and 17 closed out — a net gain of 48 holders — while 77 added to existing stakes and 82 trimmed.

The largest buyer was BlackRock, adding an estimated $16.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $35.4M.

  • 255 institutional investors held Select Medical (SEM) as of Q1 2021, up from 208 in Q4 2020.
  • Funds reported $3.53B of Select Medical stock for Q1 2021, up 24% quarter-over-quarter.
  • 65 funds opened new Select Medical positions in Q1 2021 and 17 closed out, a net change of +48 holders.
  • The largest Select Medical buyer in Q1 2021 was BlackRock, an estimated $16.2M added.
  • The largest Select Medical seller in Q1 2021 was T. Rowe Price Associates, an estimated $35.4M sold.

Based on aggregated 13F filings for Q1 2021.